Lena Biosciences is a biotechnology company offering breakthrough products that enable scientists in pharmaceutical companies, contract research organizations, cancer centers and academic labs to grow miniature human organs and accurately test drugs prior to their use with live subjects.
The company’s innovation has been vetted by the National Institutes of Health and the National Science Foundation through their small business award programs and the Georgia Research Alliance grant programs. This has led to commercialization of products with company-owned intellectual property protection that provide pioneering solutions for testing slow-clearing drugs, long-acting drugs, and small molecule therapeutics in extended exposure and/or in repeat dose. SeedEZ enables scientists to grow cells in three dimensions, mimicking function of live organs on a small scale, for scientific research and drug testing. GradientEZ expands on micro-organ technology facilitating both cell trafficking studies as they relate to cancer, immune, inflammatory, and infectious diseases and the associated testing of therapeutics and combination therapies.
Currently, Lena Biosciences is developing high-throughput organ-on-a-chip like technology poised to revolutionize preclinical testing of injectable medications and cell-based therapies. With a built-in circulation-mimicking perfusion and vasculature this micro-organ technology will provide game changing solution for de-risking frontline therapy candidates that are inactive in animals.